Top Markets
Coin of the day
Immunovia AB Immunovia AB

Immunovia AB

IMMNOV
Rank in Stocks #34136
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Share Price
$0.018005
Last synced: 2026-08-14
Market Cap
$6.17M
Change (1 day)
-1.71%
Change (1 year)
-60.12%
Country
SE
Trade Immunovia AB (IMMNOV)

Category

P/B ratio for Immunovia AB (IMMNOV)
P/B ratio as of 2026 TTM: 0
According to Immunovia AB latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Immunovia AB from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US